254 related articles for article (PubMed ID: 10853407)
1. [Role of the p53 and bcl-2 genes in apoptosis and drug resistance of tumors].
Luk'ianova NIu; Kulik GI; Chehun VF
Vopr Onkol; 2000; 46(2):121-8. PubMed ID: 10853407
[No Abstract] [Full Text] [Related]
2. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.
Kutuk O; Arisan ED; Tezil T; Shoshan MC; Basaga H
Carcinogenesis; 2009 Sep; 30(9):1517-27. PubMed ID: 19578044
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines.
Madigan MC; Chaudhri G; Penfold PL; Conway RM
Oncol Res; 1999; 11(7):331-7. PubMed ID: 10757447
[TBL] [Abstract][Full Text] [Related]
5. [p53-mediated apoptosis].
Miyashita T
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1657-63. PubMed ID: 9279095
[No Abstract] [Full Text] [Related]
6. Bcl-2 family members as molecular targets in cancer therapy.
Marzo I; Naval J
Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
[TBL] [Abstract][Full Text] [Related]
7. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL
Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
[TBL] [Abstract][Full Text] [Related]
9. p53 and response to chemotherapy and radiotherapy.
Ruley HE
Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
[No Abstract] [Full Text] [Related]
10. Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs.
Malerba I; Gribaldo L; Diodovich C; Carloni M; Meschini R; Bowe G; Collotta A
Toxicol In Vitro; 2005 Jun; 19(4):523-32. PubMed ID: 15826810
[TBL] [Abstract][Full Text] [Related]
11. Classic and novel roles of p53: prospects for anticancer therapy.
Fuster JJ; Sanz-González SM; Moll UM; Andrés V
Trends Mol Med; 2007 May; 13(5):192-9. PubMed ID: 17383232
[TBL] [Abstract][Full Text] [Related]
12. Cancer. DNA damage, deamidation, and death.
Li C; Thompson CB
Science; 2002 Nov; 298(5597):1346-7. PubMed ID: 12434041
[No Abstract] [Full Text] [Related]
13. Apoptosis: future directions in cancer therapy.
Ravi D; Panikkar KR; Nair MK; Pillai MR
Natl Med J India; 2000; 13(2):71-8. PubMed ID: 10835853
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in the development and treatment of cancer.
Gerl R; Vaux DL
Carcinogenesis; 2005 Feb; 26(2):263-70. PubMed ID: 15375012
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis: its role in the progression of and chemotherapy for carcinoma.
Meterissian SH
J Am Coll Surg; 1997 Jun; 184(6):658-66. PubMed ID: 9179126
[No Abstract] [Full Text] [Related]
16. Apoptosis and cancer mechanisms.
Pan H; Yin C; Van Dyke T
Cancer Surv; 1997; 29():305-27. PubMed ID: 9338106
[TBL] [Abstract][Full Text] [Related]
17. Death squads enlisted by the tumour suppressor p53.
Michalak E; Villunger A; Erlacher M; Strasser A
Biochem Biophys Res Commun; 2005 Jun; 331(3):786-98. PubMed ID: 15865934
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
19. Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism.
Gardner CR
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1157-77. PubMed ID: 15606340
[TBL] [Abstract][Full Text] [Related]
20. Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?
Blagosklonny MV
Bioessays; 2001 Oct; 23(10):947-53. PubMed ID: 11598961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
